Subtenon Triamcinolone Acetonide Removal for Uncontrolled Ocular Hypertension After Posterior Subtenon Injection of Triamcinolone Acetonide
To report the control of intraocular pressure (IOP) after removal of subtenon triamcinolone acetonide (TA) plaques in patients with uncontrolled ocular hypertension after posterior subtenon injection of triamcinolone acetonide (PSTA) and to evaluate the factors associated with rapid IOP normalizatio...
Saved in:
Published in | Journal of glaucoma Vol. 25; no. 3; p. e268 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
01.03.2016
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | To report the control of intraocular pressure (IOP) after removal of subtenon triamcinolone acetonide (TA) plaques in patients with uncontrolled ocular hypertension after posterior subtenon injection of triamcinolone acetonide (PSTA) and to evaluate the factors associated with rapid IOP normalization after subtenon TA removal.
Data from 8 eyes of 7 patients receiving excision of subtenon TA plaques for uncontrolled ocular hypertension after PSTA in 1 hospital from June 2010 to December 2012 were retrospectively collected. The percentage of IOP lowering on postoperative day 1 and the time to IOP normalization after subtenon TA removal were reported. Pearson correlation analysis was used to analyze the factors for rapid IOP normalization after subtenon TA removal.
The IOP lowering on postoperative day 1 ranged from 12% to 75%. All cases achieved IOP normalization within a mean of 2.5±1.9 days (range, 1 to 5 d) after subtenon TA removal. Fewer kinds of antiglaucoma agents used before subtenon TA removal was associated with greater IOP lowering on postoperative day 1 (P=0.01) and more rapid return to normal IOP (P=0.01). Older age and more time from PSTA to ocular hypertension were both correlated with shorter time to achieve IOP normalization after operation (P=0.01 and 0.02, respectively).
In medically uncontrolled ocular hypertension after PSTA, excision of subtenon TA plaques provided IOP normalization as rapidly as 1 to 5 days. Fewer preoperative antiglaucoma agents, older age, and more time from PSTA to ocular hypertension were correlated with more rapid IOP normalization after subtenon TA removal. |
---|---|
AbstractList | To report the control of intraocular pressure (IOP) after removal of subtenon triamcinolone acetonide (TA) plaques in patients with uncontrolled ocular hypertension after posterior subtenon injection of triamcinolone acetonide (PSTA) and to evaluate the factors associated with rapid IOP normalization after subtenon TA removal.
Data from 8 eyes of 7 patients receiving excision of subtenon TA plaques for uncontrolled ocular hypertension after PSTA in 1 hospital from June 2010 to December 2012 were retrospectively collected. The percentage of IOP lowering on postoperative day 1 and the time to IOP normalization after subtenon TA removal were reported. Pearson correlation analysis was used to analyze the factors for rapid IOP normalization after subtenon TA removal.
The IOP lowering on postoperative day 1 ranged from 12% to 75%. All cases achieved IOP normalization within a mean of 2.5±1.9 days (range, 1 to 5 d) after subtenon TA removal. Fewer kinds of antiglaucoma agents used before subtenon TA removal was associated with greater IOP lowering on postoperative day 1 (P=0.01) and more rapid return to normal IOP (P=0.01). Older age and more time from PSTA to ocular hypertension were both correlated with shorter time to achieve IOP normalization after operation (P=0.01 and 0.02, respectively).
In medically uncontrolled ocular hypertension after PSTA, excision of subtenon TA plaques provided IOP normalization as rapidly as 1 to 5 days. Fewer preoperative antiglaucoma agents, older age, and more time from PSTA to ocular hypertension were correlated with more rapid IOP normalization after subtenon TA removal. |
Author | Hsu, Wei-Cherng Hsieh, Yi-Ting Chan, Li-Wei |
Author_xml | – sequence: 1 givenname: Li-Wei surname: Chan fullname: Chan, Li-Wei organization: Department of Ophthalmology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei†School of Medicine, Tzu Chi University, Hualien‡Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan – sequence: 2 givenname: Wei-Cherng surname: Hsu fullname: Hsu, Wei-Cherng – sequence: 3 givenname: Yi-Ting surname: Hsieh fullname: Hsieh, Yi-Ting |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26950466$$D View this record in MEDLINE/PubMed |
BookMark | eNp10N1KwzAUB_AgivvQNxDJC3QmaZO2l2XoVhlMdAPvRpqcQEeblLQV9gy-tBE_8MZz84fDOb8DZ4bOrbOA0A0lC0ry9K58XC3I32K5OENTymMRJRl9naBZ3x9DmzBGL9GEiZyTRIgpen8ZqwECh3e-lq2qrWuCjQsFg7O1BvwMrXuTDTbO471Vzg7eNQ1ovFVjIz1enzrwgejrgBRmAI-fXB-iDgu_emmPoIbPEWf-O3WFLoxserj-zjnaP9zvlutos12Vy2ITqZgLEVVCKCCUcq5Nyo1UKbA0JlWeSKIEIxUwrQzjvMolcE6oSDIdEyMzqZU0gs3R7ZfbjVUL-tD5upX-dPj5CvsAbuppRw |
CitedBy_id | crossref_primary_10_51847_44gUM9g3fF crossref_primary_10_1080_02713683_2020_1826979 crossref_primary_10_1007_s40278_016_17792_7 crossref_primary_10_1016_j_survophthal_2020_01_002 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1097/IJG.0000000000000296 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1536-481X |
ExternalDocumentID | 26950466 |
Genre | Journal Article |
GroupedDBID | --- .-D .Z2 0R~ 2V- 53G 5GY 5VS 8L- AAAAV AAHPQ AAIQE AARTV AASCR AAYEP ABASU ABBUW ABDIG ABJNI ABOCM ABVCZ ABXRP ABXVJ ABZAD ACCJW ACDDN ACEWG ACGFO ACGFS ACILI ACWDW ACWRI ACXJB ACXNZ ADFPA ADGGA ADHPY ADNKB AE3 AE6 AEETU AENEX AFDTB AFUWQ AGINI AHQNM AHRYX AHVBC AINUH AJIOK AJNWD AJNYG AJZMW ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AWKKM BQLVK BS7 C45 CGR CS3 CUY CVF DIWNM DU5 DUNZO E.X EBS ECM EEVPB EIF EJD EX3 F2K F2L F5P FCALG FL- GNXGY GQDEL H0~ HLJTE HZ~ IKREB IN~ IPNFZ JK3 JK8 K8S KD2 KMI L-C N9A NPM N~M O9- OCUKA ODA OJAPA OL1 OLG OLV OLW OLZ OPUJH ORVUJ OUVQU OVD OVDNE OXXIT P-K P2P R58 RIG RLZ S4R S4S TEORI TSPGW V2I W3M WOQ WOW X3V X3W YFH ZB8 ZFV ZZMQN |
ID | FETCH-LOGICAL-c3566-b66ce01155df75fac7e2730b94a0c620be2dcf255b9ae5501648d30fa8adcaf62 |
IngestDate | Tue Aug 27 13:56:34 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c3566-b66ce01155df75fac7e2730b94a0c620be2dcf255b9ae5501648d30fa8adcaf62 |
PMID | 26950466 |
ParticipantIDs | pubmed_primary_26950466 |
PublicationCentury | 2000 |
PublicationDate | 2016-March |
PublicationDateYYYYMMDD | 2016-03-01 |
PublicationDate_xml | – month: 03 year: 2016 text: 2016-March |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Journal of glaucoma |
PublicationTitleAlternate | J Glaucoma |
PublicationYear | 2016 |
SSID | ssj0020221 |
Score | 2.1735585 |
Snippet | To report the control of intraocular pressure (IOP) after removal of subtenon triamcinolone acetonide (TA) plaques in patients with uncontrolled ocular... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | e268 |
SubjectTerms | Adult Aged Device Removal Drug Implants Female Glucocorticoids - administration & dosage Glucocorticoids - adverse effects Humans Injections, Intraocular Intraocular Pressure - physiology Macular Edema - drug therapy Male Middle Aged Ocular Hypertension - chemically induced Ocular Hypertension - physiopathology Retrospective Studies Tenon Capsule - drug effects Tonometry, Ocular Triamcinolone Acetonide - administration & dosage Triamcinolone Acetonide - adverse effects |
Title | Subtenon Triamcinolone Acetonide Removal for Uncontrolled Ocular Hypertension After Posterior Subtenon Injection of Triamcinolone Acetonide |
URI | https://www.ncbi.nlm.nih.gov/pubmed/26950466 |
Volume | 25 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtswFCScFgh6Cbqle8FDr3RlSiatoxG0dQIkvThoegrEDVEQJ0Eb55BfyAf0dztcJKuuDbj1QTBEmKQ1I3Ie8RZCPgxyV3DNHXOZtAwKnLPSBwJjGSyNMNiEpA8UPjwSk-Pi4GR40uv96ngtzW9UX9-tjCv5H1RxD7j6KNl_QLbtFDfwHfjiCoRx3QhjvPWQvMBvisFmuvZn5BCNY22h6GrjSzLMrm5jiCLUZXJLv4DG_BrdTyewQn8EH3Z0Mg7lwn31XswdP2h73788t7pRlmuGWiNyIc7n-OcLd6CzFOtQs2-2bjn1cx58_WzN9sChtJmGhtqGc5_vNZs2m2w6oxiIhZNW3zbrqmDFKFTHaRfeGPGcCJZ3VlHLY6mdv5b3mDZ4_-BLTDvZfHgsittB_HoWIOeiHGaF2KB1Kel207RFtuTIL59H_hAo2fGQPYMmCrOUH1dNx-eYTl0s2StBt0wfk52EBR1H9jwhPXv5lGwfJpeKZ-S-gZn-gSxtkaWJRBQkol0S0Ugi2iURDSSiLYlo23tLInrl1g31nBx__jTdm7BUoYPpHHYAU0Jo642KoXFy6CotLeRwpsqiyrTgmbLcaAerVZWVhS0M23xk8sxVo8roygm-Sx5gCvYloT6VZaGxv8hSQcJLVUhdVNYYmH-K5_kr8iI-xtPrmIbltHnAr9e2vCGPFmx8Sx46vPf2HUTkjXofIP0NTIl1Pg |
link.rule.ids | 783 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Subtenon+Triamcinolone+Acetonide+Removal+for+Uncontrolled+Ocular+Hypertension+After+Posterior+Subtenon+Injection+of+Triamcinolone+Acetonide&rft.jtitle=Journal+of+glaucoma&rft.au=Chan%2C+Li-Wei&rft.au=Hsu%2C+Wei-Cherng&rft.au=Hsieh%2C+Yi-Ting&rft.date=2016-03-01&rft.eissn=1536-481X&rft.volume=25&rft.issue=3&rft.spage=e268&rft_id=info:doi/10.1097%2FIJG.0000000000000296&rft_id=info%3Apmid%2F26950466&rft_id=info%3Apmid%2F26950466&rft.externalDocID=26950466 |